AVBP
AVBP
US04272N1028
ArriVent BioPharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
824.92M EUR
1.68B EUR
1.05B EUR
854.14M EUR
Enterprise Value
451.16M EUR
1.52B EUR
983.59M EUR
808.61M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.32x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.2x
4.58x
3.23x
2.78x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-10.85%
-8.81%
-12.86%
-10.84%
ende